Related Experiment Video
Updated: Jan 20, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
Pulmonary Sarcomatoid (Pleomorphic) Carcinoma Presenting As Secondary Spontaneous Pneumothorax in Diffuse Cystic Lung
George K Annan1, Abigail Mills-Annoh1, Jeffrey Afrifa-Yamoah2
1Internal Medicine, Piedmont Athens Regional Medical Center, Athens, USA.
Abstract:
Pulmonary sarcomatoid carcinoma is a rare and aggressive subtype of non-small cell lung cancer associated with poor prognosis and atypical clinical presentations. Spontaneous pneumothorax as an initial manifestation is exceedingly uncommon and may obscure the underlying diagnosis, particularly in patients with diffuse cystic lung disease. This report describes a case of pulmonary sarcomatoid (pleomorphic) carcinoma presenting with secondary spontaneous pneumothorax in the setting of diffuse cystic lung abnormalities, highlighting the diagnostic challenges encountered and the importance of maintaining suspicion for malignancy in atypical presentations. Early tissue diagnosis, multidisciplinary evaluation, and molecular profiling played key roles in guiding definitive management. This case underscores the need to consider lung cancer in patients presenting with spontaneous pneumothorax and atypical parenchymal findings, as timely recognition may permit curative-intent treatment and biomarker-informed systemic therapy in this aggressive malignancy.
Related Concept Videos
07:13Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
11:27Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
05:56Phase-Resolved Functional Lung MRI for Pulmonary Ventilation and Perfusion (V/Q) Assessment
07:09Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
08:44Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
04:44Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

